Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 1

Abstract

Levetiracetam (LEV) is a relatively newer anticonvulsant drug used to treat epilepsy and is approved by United States Food and Drugs Administration (USFDA). The drug binds to a synaptic vesicle glycoprotein and inhibits presynaptic calcium channels, thus reducing neurotransmitter release. Commonly reported side effects include drowsiness, weakness, unsteady gait, mood changes and loss of appetite. Like most other antiepileptics, it is a Category C drug in pregnancy. We report the first case of facial dysmorphism in the neonate of a mother taking LEV antenatally. A 30-year-old lady, G2 P1 L1 presented at 38 weeks gestation with history of previous caesarean and leaking per vaginum. She was a known epileptic, taking carbamazepine since three to four years. She was switched over to LEV at fifth week of pregnancy. Her antenatal period was uneventful. Basic investigations including anomaly scan were normal. Unfavourable cervix necessitated caesarean section. Neonate (female) had dysmorphic facies with bilateral preauricular appendages and lateral cleft. Infantogram was suggestive of bifid vertebra in thoracic region. Computed Tomography (CT) scan chest revealed bifid vertebral body at D5 level with fusion of spinous process of D5 and D6 vertebra on left side. This is the first case of LEV induced facial dysmorphism, highlighting the need of further studies on LEV safety during pregnancy.

Authors and Affiliations

Jyotsana Gupta, Sandhya Jain, Shalini Rajaram, Neerja Goel, Bindiya Gupta

Keywords

Related Articles

Role of Multivoxel Intermediate TE 2D CSI MR Spectroscopy and 2D Echoplanar Diffusion Imaging in Grading of Primary Glial Brain Tumours

Introduction: Preoperative tumour grading is imperative owing to difference in invasive, aggressive tendencies of different grades of glial tumours implying varied prognosis, therapeutic options. Histopathological examin...

Giant Pyonephrosis Due to Ureteropelvic Junction Obstruction: A Case Report

Pyonephrosis is a suppurative infection of upper urinary tract due to obstruction of the ureter. It is usually associated with suppurative damage of renal parenchyma and renal function loss. Patients are mostly symptomat...

Prediction of the Dimensions of the Spiritual Well-Being of Students at Kermanshah University of Medical Sciences, Iran: The Roles of Demographic Variables

Introduction: Spiritual well-being is one of the aspects of wellbeing which organize the physical, psychological, and social aspects. Given the outstanding and unique roles of students in society, providing spiritual wel...

Modulatory Role of Mucuna pruriens against Aluminium Fluoride Induced Neuronal and Behavioural Alterations in Rats

ABSTRACT Introduction: Aluminium Fluoride (AlF3) intake produces oxidative stress resulting in brain damage. Although Mucuna pruriens (Velvet bean) is commonly used in ayurvedic system of medicine for different neurologi...

Speckle Tracking Echocardiography in the Diagnosis of Subclinical Left Ventricular Systolic Dysfunction in Hypertensive Patients

ABSTRACT Introduction: The early diagnosis of subclinical left ventricular systolic dysfunction in hypertensive patients is of crucial importance to prevent further adverse events and the onset of tissue and organ compli...

Download PDF file
  • EP ID EP328447
  • DOI 10.7860/JCDR/2017/23824.9269
  • Views 159
  • Downloads 0

How To Cite

Jyotsana Gupta, Sandhya Jain, Shalini Rajaram, Neerja Goel, Bindiya Gupta (2017). Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam. Journal of Clinical and Diagnostic Research, 11(1), 8-9. https://europub.co.uk/articles/-A-328447